Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Narrative) (Details)

v3.23.1
Related Party Transactions (Narrative) (Details) - USD ($)
3 Months Ended
May 11, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]        
Revenue from TGTX   $ 35,000 $ 52,000  
Total notes payable   92,314,000   $ 91,730,000
Interest expense, interest   $ 3,320,000 1,961,000  
Avenue Therapeutics, Inc [Member]        
Related Party Transaction [Line Items]        
Paid in Kind dividend as a percentage of fully diluted outstanding capitalization   2.50%    
Journey        
Related Party Transaction [Line Items]        
Proceeds from Related Party Agreement   $ 15,000 100,000  
Chief Executive Officer (Dr. Rosenwald) [Member]        
Related Party Transaction [Line Items]        
Interest own in percent by principal stockholder or director   11.80%    
Executive Vice Chairman [Member]        
Related Party Transaction [Line Items]        
Interest own in percent by principal stockholder or director   11.30%    
Shared Services Agreement [Member] | TGTX [Member]        
Related Party Transaction [Line Items]        
Revenue from TGTX   $ 100,000 100,000  
Desk Share Agreements [Member] | TGTX [Member] | New York, NY Office Space [Member]        
Related Party Transaction [Line Items]        
Revenue from TGTX   500,000 500,000  
Related party transaction, receivables   300,000    
Total payment for rent   $ 800,000 $ 900,000  
Stock Contribution Agreement [Member] | Avenue Therapeutics, Inc [Member]        
Related Party Transaction [Line Items]        
Percentage of common and preferred shares to be transferred to partner company. 100.00%      
Minimum proceeds required for closing of equity financing $ 7,500,000      
Percentage of partner company shares to be repurchased by partner company in stock contribution agreement 100.00%